Africa Herbal Antimalaria Meeting Nairobi, 20-22 March 2006 Research on Traditional Medicines used for the Treatment of Malaria in WHO African Region Traditional.

Slides:



Advertisements
Similar presentations
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Advertisements

TUBERCULOSIS Tuberculosis (TB) is a contagious disease. If left untreated, it can be fatal. The largest number of TB cases in 2005 were in South-East Asia.
Pneumonia: Past and Present
Doctors For Life International: An NGO’s perspective on Malaria in Southern Africa Bola Omoniyi, Ph.D. http:
METHODOLOGY FOR THE REVIEW/EVALUATION OF POLICY DOCUMENTS By Kwami DADJI, Health Officer HIV/AIDS, TB, Malaria & OID African Union Commission.
Malaria  Malaria is a vector borne parasitic disease caused by the genus Plasmodium, affecting over 100 countries of the tropical and subtropical regions.
MEASURE Evaluation M&E and Advocacy Tools in the response to the Emergency Declaration.
AIDS/Other Diseases Sub-Saharan Africa.
The Work of WHO in the South-East Asia Region The Work of WHO in the South-East Asia Region Biennial Report of the Regional Director 1 January
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
EQUI - TB Knowledge Programme Quality Assured TB Care for Poor People in Resource Constrained settings 2001 – 2006 Purpose: To promote implementation of.
22 March 2012 Europe and ACP together against tuberculosis European Parliament, Rue Wiertz 60 BRUSSELS Charles S Mgone EDCTP Executive Director.
Epilepsy and WHO | 17 Oct |1 | Demonstration Projects General Objectives –Reduce treatment gap and social and physical burden –Educate health personnel.
One SADC, One Vision, One Way Working Together Towards MDG 6: SADC’s Common Vision Hon. Benedict Xaba, Minister of Health of Swaziland International AIDS.
Integration of HIV/AIDS into APRM Bunmi Makinwa UNAIDS Country Coordinator/Ethiopia and Representative for African Regional Organizations.
IATT Annual Meeting Adolescent and Young People participation In the fight against HIV/AIDS in Africa Presented by: Ms. Aidah Nakanjako AfriYAN April 16,
U.S. Public Health Assistance to Africa by Michael Hall.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
European and Developing Countries Clinical Trials Partnership AEMI Seminar Dec 2010 Dr Thomas Nyirenda South-South Networking and Capacity Development.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
Worldwide Importance of Certain Diseases LESSON OBJECTIVE: Discuss the global impact of malaria, HIV/AIDS and TB.
Achieving EFA Goals through Quality Basic Education for OVCs: A study of the Implementation of the HIV/AIDS Education Sector Policy in Kenya A presentation.
Improving Access and Quality Use of Medicines in Palliative Care within National Drug Policy, Regulatory, and Funding Frameworks Debra Rowett, Tania Shelby-James,
An Overview of TB in SAARC Countries and Role of SAARC TB Centre in TB Control Dr Paras K Pokharel, Associate Professor Dept. of Community Medicine, BPKIHS.
European HIV/AIDS programmes: EDCTP as a model of Europe-Africa partnership 19 July 2011 IAS 2011 Rome, Italy Charles S Mgone EDCTP Executive Director.
AIDS in Sub Saharan Africa AIDS – a virus with no known cure first identified in the Belgian Congo in It’s now a global epidemic, and poverty and.
Ami R. Moore, PhD Department of Sociology University of North Texas 12/01/2011.
PEPFAR Investment Strategy (8 years of PEPFAR) Data source : OGAC Budget Total PEPFAR Investment: $21,285,918,291 Saving Lives : Changing the.
Global Health World Health Organization (WHO)(WHO) UN AIDS World Bank – Health, Nutrition, and PopulationHealth, Nutrition, and Population CIA Report:
L THE EXPLODING GLOBAL HIV/AIDS PANDEMIC. l THE POTENTIAL ENORMITY OF THE HIV/AIDS PANDEMIC IS PROFOUND.
Burden of disease: Concepts and applications. Session Aims 1.to introduce the concept “burden of disease” 2.to examine patterns and trends in mortality.
MILLENIUM DEVELOPMENT GOALS Board review Notes Dr. Theresita R. Lariosa.
Urbanization, Wealth and Overweight in Sub- Saharan Africa Nyovani Madise & Gobopamang Letamo* *University of Botswana 12 th June Population Health.
AFRICA HIV/AIDS AIDS DATA SOURCE: UNAIDS 2007 REPORT WORLD HEALTH ORGANIZATION.
Larval Source Management in Africa: Case Studies Charles M. Mbogo Kenya Medical Research Institute, Centre for Geographic Medicine Research, Kilifi.
WHO activities related to WHA58.26 | 11. August |1 | WHA resolution on alcohol (2005): background and follow up activities by the WHO Secretariat.
THE ROLE OF WHO, UNICEF AND NEPAD IN NURSING UNICEF WHO.
WHO Prequalification of Medicines: a gateway to the global pharmaceutical market Introduction 28 June 2014, Shanghai Milan Smid.
AIDS 8, 493 deaths per day 3.1 million deaths per year (2004 WHO estimates) More than 90% of those infected with HIV/AIDS live in developing countries.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
Using implementation science to improve child household contact screening for tuberculosis in Eldoret, Kenya: Overview and lessons learned Daria Szkwarko,
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
4 th SIDS Meeting, Sao Tome & Principe April 2013 Universal Health Coverage: Important challenges and policy issues that SIDS have to face.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
World Health Organization
Somya Gupta, Reuben Granich
Tuberculosis in children
UN Regional Workshop on the 2020 World Program on Population and Housing Censuses: International Standards and Contemporary Technologies Lusaka, Zambia,
PROMETRA International
deaths per year (2013 WHO estimates)
Trade Union Training on the Validation of the training manual entitled “Union Training on Occupational Safety and Health” HEALTH & HIV/AIDS.
Tuberculosis (TB): The 22 High-Burden Countries (HBCs)
HIV/AIDS in sub-Saharan Africa July 2002
Access to Antimalarial Medicines
Access framework HIV/AIDS, TB and Malaria
Developing pharmacovigilance: new challenges and opportunities Mary Couper and Shanthi Pal Quality Assurance and Safety of Medicines.
TB-HIV Last updated: March 2018.
By: Dr Mirzaei.
World Health Organization
Pharmacovigilance What? (2.6) Ensure ADR monitoring (Spontaneous reporting/Cohort studies) Who? Healthcare workers How? WHO International Drug Monitoring.
TB-HIV Last updated: November 2018.
Medicine in third world countries
وضعیت بیماری سل در جهان، منطقه و ایران
Key issues in DOTS implementation
Essential Drugs and Medicines Policy (EDM) World Health Organization
SOEH International Conference on Pesticide Exposure and Health-8-12 July 2002 TO EQUIP COUNTRIES WITH THE BEST KNOWLEDGE AND ABILITY TO ENSURE THE HEALTH.
Pediatric HIV Case Finding Strategies
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Presentation transcript:

Africa Herbal Antimalaria Meeting Nairobi, March 2006 Research on Traditional Medicines used for the Treatment of Malaria in WHO African Region Traditional Medicine Programme, WHO Regional Office for Africa, Brazzaville, Congo Presented by Dr Mawuli W. Kofi-Tsekpo, PhD Kenya Medical Research Institute (KEMRI) Member of WHO Regional Expert Committee on Traditional Medicine

Malaria Burden of Disease 1.The prevalence of malaria has been escalating at an alarming rate and an estimated million cases each year cause 1.5 to 2.7 million deaths. 2.More than 90% of the deaths are in children under 5 years of age in Africa. 3.Malaria (which accounts for 9% of global disease burden) ranks third among major infectious disease threats in Africa after pneumococcal acute respiratory infections (3.5%) and tuberculosis (TB) (2.8%). 4.Malaria cases in Africa account for approximately 90% of malaria cases in the world. 5.Between 1994 and 1996, malaria epidemics in 14 countries of Sub- Saharan Africa caused an unacceptably high number of deaths, many in areas previously free of the disease. Adolescents and young adults are now dying of severe forms of the disease.

Factors favouring the spread of malaria Resistance of parasite to drugs is confounded by regional conflicts forcing mass migration of people to or from infected areas, and migration of non- immune people to infected areas for agricultural reasons Changing rainfall patterns favouring mosquito breeding sites. Adverse socioeconomic conditions leading to inadequate health budget to fight malaria

Policy orientations and Commitment of countries and WHO Adoption of Regional Strategy by – RC50 The April 2001-Abuja Declaration on research of traditional medicines The July Lusaka Declaration on the decade of African TM ( ) Adoption of global TRM Strategy Malaria, HIV/AIDS, TB and Other Infectious Diseases Adoption of Plan of Action in 2003 in Tripoli WHA56.13 Ouagadougou, 2000 Alma Ata Declaration, 1978

The Regional Strategy Promoting the Role of Traditional Medicine in Health Systems: A Strategy for the African Region. AFR/RC50/R3: - Resolution of the Regional Committee 31 August 2000

Research Methodology General Objective Specific Objectives Preclinical Evaluation/ Retrospective Study /Ethnomedical Evidence Methodology Criteria for patient selection (including Inclusion criteria and exclusion criteria) Sample size Screening Phase Serum chemistries Haematology Treatment Phase INFORMED CONSENT

Research Methodology Drug Administration Traditional Herbal Remedy to be tested Control treatment Parasitaemia Serum chemistries Haematology Physical examination and vital signs Electrocardiogram (ECG) examinations Assessment of Efficacy a) Primary outcome measures b) Secondary outcome measures (optional) Assessment of Safety Discontinuation from the study

Countries that are conducting research of traditional medicines used for malaria Burkina Faso DRC Ghana Kenya Madagascar Mozambique Nigeria South Africa Tanzania Zambia Zimbabwe The ability to conduct research and the tools and guidelines do exist. However, there is need to build the culture for research in the Region.

Nascent pilot farms of Artemisia annua in Zimbabwe (Source: WHO/AFRO, 2006)

Countries locally producing in small-scale traditional medicines for Malaria and HIV/AIDS in WHO African Region (Source: WHO/AFRO, 2006) Malaria Countries producing medicines for Malaria EMRO Countries Regions Others countries

The Role of WHO in Research To provide technical (and financial) support to research institutions and WHO Collaborating centres for research to produce evidence of TMs used for malaria and other priority diseases To produce tools and guidelines on research methodology for adaptation by countries: Clinical evaluation of traditional medicines in WHO African Region, Brazzaville, (AFR/EDM/ TRM/04.04) WHO Guidelines on research methodologies and traditional medicine, Geneva, (WHO/EDM/TRM/2002.1). Monograph on Artemisia Annua (of which I was chairperson during its review in China) Guidelines on Good Agricultural and Collection practices of medicinal plants, 2004

Traditional Medicine is our own, if we Africans do not develop it, nobody else will